Pancreatic Cancer Research

ResearcherTUM KlinikumNo recent work listed

Laura Conradt

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5059037591. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper

Papers 2

  1. Mdm2 inhibitors synergize with topoisomerase II inhibitors to induce p53-independent pancreatic cancer cell death. Co-author DOI 10.1002/ijc.27916↗
  2. Disclosure of erlotinib as a multikinase inhibitor in pancreatic ductal adenocarcinoma. Co-author DOI 10.1593/neo.111016↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Roland Michael Schmid · 2 shared papers, 2011–2013 · strength 0.06
  2. Günter Schneider · 2 shared papers, 2011–2013 · strength 0.06
  3. Dieter Saur · 2 shared papers, 2011–2013 · strength 0.06
  4. Marina Lesina · 1 shared paper, 2013 · strength 0.03
  5. Maximilian Reichert · 1 shared paper, 2013 · strength 0.03
  6. Oliver Holger Krämer · 1 shared paper, 2013 · strength 0.03
  7. Hana Algül · 1 shared paper, 2013 · strength 0.03
  8. Matthias Wirth · 1 shared paper, 2013 · strength 0.03
  9. Sandra Diersch · 1 shared paper, 2011 · strength 0.02
  10. Stefan Eser · 1 shared paper, 2011 · strength 0.02
  11. Christoph W. Michalski · 1 shared paper, 2011 · strength 0.02
  12. Jorg H. Kleeff · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.